vx 497 has been researched along with ag-490 in 1 studies
| Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (ag-490) | Trials (ag-490) | Recent Studies (post-2010) (ag-490) |
|---|---|---|---|---|---|
| 25 | 3 | 7 | 732 | 2 | 322 |
| Protein | Taxonomy | vx 497 (IC50) | ag-490 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.9224 | |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 3.38 | |
| large T antigen | Betapolyomavirus macacae | 14.61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandraratna, RA; Nagpal, S; Thacher, SM; Tsang, KY; Vasudevan, J | 1 |
1 review(s) available for vx 497 and ag-490
| Article | Year |
|---|---|
New dermatological agents for the treatment of psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Cholecalciferol; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Ligands; Methotrexate; Psoriasis; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Vitamin A | 2001 |